1. A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma. (1st January 2006) Authors: Valerio, M. R.; Tagliaferri, P.; Raspagliesi, F.; Fulfaro, F.; Badalamenti, G.; Arcara, C.; Cicero, G.; Russo, A.; Venuta, S.; Guarneri, G.; Gebbia, N. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 1 Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Γδ T Cell-Based Immunotherapy in Melanoma: State of the Art. (23rd May 2019) Authors: Toia, F.; Di Stefano, A. B.; Meraviglia, S.; Lo Presti, E.; Pirrello, R.; Rinaldi, G.; Fulfaro, F.; Dieli, F.; Cordova, A. Other Names: Pant Aditya B. Guest Editor. Journal: Journal of oncology Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗